Ashwagandha () for promoting recovery in long covid: protocol for a randomised placebo-controlled clinical trial (APRIL Trial).

Background: Long covid describes a syndrome of persistent symptoms following COVID-19 and is responsible for substantial healthcare and economic burden. Currently, no effective treatments have been established. Ashwagandha () is a medicinal herb traditionally used in India for its immune-strengthening and anti-inflammatory properties.